Maya Ghoussaini completed a PhD degree in Molecular Genetics at the Pasteur Institute of Lille, France. In 2007, she moved to the Department of Oncology at the University of Cambridge where her research focussed on Genome Wide Association Studies for breast cancer and the identification of genetic variants that increase cancer risk. In 2015, she moved to the Department of Pharmacology at the University of Cambridge where she used genome editing (CRISPR/Cas9) to understand how and why these genetic variants increase breast cancer risk, impact cancer cell behaviour and affect target gene expression. Since April 2017, Dr. Ghoussaini joined the Wellcome Sanger Institute as Genetic Analysis Team Leader within Open Targets. Her team integrates genetics and genomics data to improve target identification and prioritisation.? Dr. Ghoussaini is also a Course Director and a tutor for the Undergraduate Certificate in Genetics at the University of Cambridge.